Search Results - "LaForce, C F"

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring by Philip, G., Malmstrom, K., Hampel Jr, F. C., Weinstein, S. F., LaForce, C. F., Ratner, P. H., Malice, M.-P., Reiss, T. F.

“…Summary Background Cysteinyl leukotrienes are important proinflammatory mediators believed to have a role in allergic rhinitis. Objective This multicentre,…”
Get full text

Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma by Shapiro, Gail, Bronsky, Edwin A., LaForce, Craig F., Mendelson, Louis, Pearlman, David, Schwartz, Robert H., Szefler, Stanley J.

“…Objective: To determine the efficacy and safety of budesonide delivered by an inhalation-driven dry powder inhaler (Turbuhaler) in children with moderate to…”
Get full text

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis by Casale, Thomas B., Bernstein, I.Leonard, Busse, William W., LaForce, Craig F., Tinkelman, David G., Stoltz, Randall R., Dockhorn, Robert J., Reimann, James, Su, John Q., Fick, Robert B., Adelman, Daniel C.

“…Background: Increased serum levels of antigen-specific IgE are often associated with allergic respiratory disorders. RhuMAb-E25, a recombinant humanized…”
Get full text

Formoterol Delivered via the Dry Powder Aerolizer® Inhaler Versus Albuterol MDI and Placebo in Mild-to-Moderate Asthma: A Randomized, Double-Blind, Double-Dummy Trial by Pleskow, W., LaForce, C. F., Yegen, Ü., Matos, D., Della Cioppa, G.

“…The objectives of this study were to compare the efficacy and tolerability of twice-daily formoterol dry powder 12 µg and 24 µg (Foradil) delivered via…”
Get full text

A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology by Meltzer, E O, Orgel, H A, Bronsky, E A, Furukawa, C T, Grossman, J, LaForce, C F, Lemanske, Jr, R F, Paull, B D, Pearlman, D S, Ratner, P H

“…Fluticasone propionate is a new glucocorticosteroid with potent topical activity. In a double-blind, randomized, parallel-group study, 423 adult patients with…”
Get more information

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring by Philip, G., Malmstrom, K., Hampel Jr, F. C., Weinstein, S. F., LaForce, C. F., Ratner, P. H., Malice, M.-P., Reiss, T. F.

Get full text

A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease by Kharidia, J, Fogarty, C.M, LaForce, C.F, Maier, G, Hsu, R, Dunnington, K.M, Curry, L, Baumgartner, R.A, Hanrahan, J.P

“…Abstract Background Arformoterol is a single-isomer ( R , R -formoterol) nebulized long-acting β2 -agonist approved for use in patients with chronic…”
Get full text

Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect by Siler, Thomas M, LaForce, Craig F, Kianifard, Farid, Williams, James, Spangenthal, Selwyn

“…Background: Indacaterol 75 µg once daily is a long-acting [β.sub.2] agonist approved for maintenance bronchodilator treatment in patients with chronic…”
Get full text

Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents by LaForce, C F, Dockhorn, R J, Findlay, S R, Meltzer, E O, Nathan, R A, Stricker, W, Weakley, S, Field, E A, Rogenes, P R

“…Topical corticosteroids are widely regarded as the reference standard in allergic rhinitis therapy because they are well tolerated and effective against all…”
Get more information

Growth in asthmatic children treated with fluticasone propionate by Allen, David B., Bronsky, Edwin A., LaForce, Craig F., Nathan, Robert A., Tinkelman, David G., Vandewalker, Mark L., Konig, Peter

“…Objective: To determine whether inhaled fluticasone propionate has long-term effects on growth in children with persistent asthma. Study Design: In a…”
Get full text

Use and acceptance of ventolin Rotacaps and the Rotahaler in 1235 asthmatic patients by LaForce, C F, Ellis, E F, Kordansky, D W, Cocchetto, D M, Sharp, J T

“…This open-label study was performed to characterize the acceptance, reliability, and adverse event profile of a dry powder delivery system for albuterol. A…”
Get more information

Inhibition of methylprednisolone elimination in the presence of erythromycin therapy by LaForce, C F, Szefler, S J, Miller, M F, Ebling, W, Brenner, M

“…Methylprednisolone elimination is reduced in the presence of treatment with troleandomycin (TAO), a macrolide antibiotic. To assess whether a similar…”
Get more information

Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma by LaForce, C F, Pearlman, D S, Ruff, M E, Silvers, W S, Weinstein, S W, Clements, D S, Brown, A, Duke, S, Harding, S M, House, K W

“…Flovent Diskus is a powder formulation of the inhaled corticosteroid fluticasone propionate (FP) delivered via a breath-actuated, multidose inhaler. To…”
Get more information

Kimura's disease: report of a pediatric case in the United States by Hamrick, H J, Jennette, J C, LaForce, C F

“…A 14-year-old male adolescent is described with a 6-year history of active lymphadenopathy, skin rash, peripheral blood eosinophilia, and markedly elevated…”
Get more information

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study by LaForce, Craig, Feldman, Gregory, Spangenthal, Selwyn, Eckert, Joerg H, Henley, Michelle, Patalano, Francesco, D'Andrea, Peter

“…The purpose of this study was to confirm the efficacy and safety of twice-daily glycopyrrolate 15.6 µg, a long-acting muscarinic antagonist, in patients with…”
Get full text

Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis by Nathan, R A, Bronsky, E A, Fireman, P, Grossman, J, LaForce, C F, Lemanske, Jr, R F, Pearlman, D S, Ratner, P H, Rogenes, P R

“…A multicenter double-blind, randomized, parallel group study was conducted to evaluate the once daily administration of fluticasone propionate, a potent, new…”
Get more information

Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis by Banov, C H, Woehler, T R, LaForce, C F, Pearlman, D S, Blumenthal, M N, Morgan, W F, Frazer, H, Southern, D L, Gold, B, Field, E

“…The efficacy of intranasal fluticasone propionate 200 micrograms once daily or 100 micrograms twice daily in treating perennial allergic rhinitis was evaluated…”
Get more information

Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma by Pierson, W E, LaForce, C F, Bell, T D, MacCosbe, P E, Sykes, R S, Tinkelman, D

“…This parallel-group study compared the safety and efficacy of controlled-release albuterol versus sustained-release theophylline, both administered every 12…”
Get more information

Effect of erythromycin on theophylline clearance in asthmatic children by LaForce, C F, Miller, M F, Chai, H

“…Fifteen asthmatic children (mean age = 14.5 years) who required daily theophylline therapy were studied for effect of erythromycin ethyl-succinate on…”
Get more information

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma by Lipworth, Brian J, Kaliner, Michael A, LaForce, Craig F, Baker, James W, Kaiser, Harold B, Amin, Dilip, Kundu, Sudeep, Williams, James E, Engelstaetter, Renate, Banerji, Donald D

“…Despite their proven efficacy in the treatment and prevention of asthma exacerbations, current inhaled corticosteroids carry safety concerns, especially…”
Get more information